Ha habido 45 transacciones internas recientes registradas para Sionna Therapeutics, Inc. (SION), incluyendo 14 compras y 31 ventas. El total de compras internas fue valorado en $42.25M y el total de ventas internas en $32.03M.
Internos destacados con actividad reciente incluyen Fitzpatrick Jennifer, Orbimed Advisors Llc, Thompson Peter A.. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — SION
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-05 |
Fitzpatrick Jennifer |
Chief Legal Officer |
Venta Informativa |
10,250 |
$33.86 |
$347.02K |
- |
| 2026-02-03 |
Orbimed Advisors Llc |
Director |
Venta Informativa |
29,063 |
$44.58 |
$1.3M |
3,530,702 |
| 2026-02-03 |
Thompson Peter A. |
Director |
Venta Informativa |
29,063 |
$44.58 |
$1.3M |
3,530,702 |
| 2026-02-02 |
Orbimed Advisors Llc |
Director |
Venta Informativa |
1,890 |
$44.57 |
$84.24K |
3,559,765 |
| 2026-02-02 |
Thompson Peter A. |
Director |
Venta Informativa |
1,890 |
$44.57 |
$84.24K |
3,559,765 |
| 2026-01-22 |
Tpg Gp A, Llc |
10 Percent Owner |
Venta Informativa |
250,000 |
$40.00 |
$10M |
6,494,962 |
| 2026-01-02 |
Cloonan Michael |
President & CEO |
Concesión de RSU |
436,100 |
$39.21 |
$17.1M |
436,100 |
| 2026-01-02 |
Ridloff Elena |
CFO |
Concesión de RSU |
165,440 |
$39.21 |
$6.49M |
165,440 |
| 2026-01-02 |
Mckee Charlotte |
Chief Medical Officer |
Concesión de RSU |
155,700 |
$39.21 |
$6.1M |
155,700 |
| 2026-01-02 |
Fitzpatrick Jennifer |
Chief Legal Officer |
Concesión de RSU |
103,140 |
$39.21 |
$4.04M |
103,140 |
| 2026-01-02 |
Beer Caroline Stark |
Chief Business Officer |
Concesión de RSU |
139,340 |
$39.21 |
$5.46M |
139,340 |
| 2025-12-24 |
Orbimed Advisors Llc |
Director |
Venta Informativa |
33,356 |
$44.55 |
$1.49M |
3,561,655 |
| 2025-12-24 |
Thompson Peter A. |
Director |
Venta Informativa |
33,356 |
$44.55 |
$1.49M |
3,561,655 |
| 2025-12-19 |
Orbimed Advisors Llc |
Director |
Venta Informativa |
875 |
$44.49 |
$38.93K |
3,595,011 |
| 2025-12-19 |
Thompson Peter A. |
Director |
Venta Informativa |
875 |
$44.49 |
$38.93K |
3,595,011 |
| 2025-12-18 |
Orbimed Advisors Llc |
Director |
Venta Informativa |
100 |
$44.49 |
$4.45K |
3,595,886 |
| 2025-12-18 |
Thompson Peter A. |
Director |
Venta Informativa |
100 |
$44.49 |
$4.45K |
3,595,886 |
| 2025-12-17 |
Orbimed Advisors Llc |
Director |
Venta Informativa |
900 |
$44.50 |
$40.05K |
3,595,986 |
| 2025-12-17 |
Thompson Peter A. |
Director |
Venta Informativa |
900 |
$44.50 |
$40.05K |
3,595,986 |
| 2025-12-05 |
Fitzpatrick Jennifer |
Chief Legal Officer |
Venta Informativa |
10,250 |
$40.52 |
$415.33K |
- |
| 2025-11-26 |
Orbimed Advisors Llc |
Director |
Venta Informativa |
1,600 |
$44.49 |
$71.18K |
3,596,886 |
| 2025-11-26 |
Thompson Peter A. |
Director |
Venta Informativa |
1,600 |
$44.49 |
$71.18K |
3,596,886 |
| 2025-11-25 |
Orbimed Advisors Llc |
Director |
Venta Informativa |
11,890 |
$44.60 |
$530.29K |
3,598,486 |
| 2025-11-25 |
Thompson Peter A. |
Director |
Venta Informativa |
11,890 |
$44.60 |
$530.29K |
3,598,486 |
| 2025-11-24 |
Orbimed Advisors Llc |
Director |
Venta Informativa |
94,583 |
$44.54 |
$4.21M |
3,610,376 |
| 2025-11-24 |
Thompson Peter A. |
Director |
Venta Informativa |
94,583 |
$44.54 |
$4.21M |
3,610,376 |
| 2025-11-21 |
Ra Capital Management, L.p. |
10 Percent Owner |
Venta Informativa |
7,609 |
$39.50 |
$300.56K |
159,033 |
| 2025-11-20 |
Ra Capital Management, L.p. |
10 Percent Owner |
Venta Informativa |
604 |
$40.50 |
$24.46K |
166,642 |
| 2025-11-19 |
Ra Capital Management, L.p. |
10 Percent Owner |
Venta Informativa |
9 |
$40.61 |
$365.49 |
168,193 |
| 2025-11-18 |
Ra Capital Management, L.p. |
10 Percent Owner |
Venta Informativa |
2,092 |
$39.57 |
$82.78K |
182,527 |
| 2025-11-17 |
Ra Capital Management, L.p. |
10 Percent Owner |
Venta Informativa |
331 |
$42.10 |
$13.94K |
184,619 |
| 2025-10-28 |
Ra Capital Management, L.p. |
10 Percent Owner |
Venta Informativa |
10,476 |
$39.58 |
$414.64K |
209,391 |
| 2025-10-24 |
Ra Capital Management, L.p. |
10 Percent Owner |
Venta Informativa |
107,941 |
$39.50 |
$4.26M |
219,867 |
| 2025-10-21 |
Booth Bruce |
Director |
Venta Informativa |
17 |
$36.42 |
$619.14 |
686,567 |
| 2025-10-21 |
Cloonan Michael |
President & CEO |
Ejercicio de Opciones (Venta) |
33,532 |
$6.11 |
$204.88K |
53,142 |
| 2025-10-16 |
Booth Bruce |
Director |
Venta Informativa |
12,888 |
$33.38 |
$430.2K |
2,479,288 |
| 2025-06-12 |
Ra Capital Management, L.p. |
10 Percent Owner |
Concesión de RSU |
19,959 |
$16.99 |
$339.1K |
19,959 |
| 2025-06-12 |
Thompson Peter A. |
Director |
Concesión de RSU |
19,959 |
$16.99 |
$339.1K |
19,959 |
| 2025-06-12 |
Clancy Paul J |
Director |
Concesión de RSU |
19,959 |
$16.99 |
$339.1K |
19,959 |
| 2025-06-12 |
Booth Bruce |
Director |
Concesión de RSU |
19,959 |
$16.99 |
$339.1K |
19,959 |
| 2025-06-12 |
Stelzer Laurie |
Director |
Concesión de RSU |
19,959 |
$16.99 |
$339.1K |
19,959 |
| 2025-06-12 |
Resnick Joshua |
Director |
Concesión de RSU |
19,959 |
$16.99 |
$339.1K |
19,959 |
| 2025-06-12 |
Viney Joanne L. |
Director |
Concesión de RSU |
19,959 |
$16.99 |
$339.1K |
19,959 |
| 2025-06-12 |
Fleming Harold Edward |
Director |
Concesión de RSU |
19,959 |
$16.99 |
$339.1K |
19,959 |
| 2025-06-12 |
Ruddy Marcella K. |
Director |
Concesión de RSU |
19,959 |
$16.99 |
$339.1K |
19,959 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
